NL-OMON49125已完成不适用
Modulation of the intestinal microbiome, and its effects on endurance exercise capacity in moderately trained individuals - Intestinal microbiome modulation and endurance exercise
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Aged from 18- 40 years
- •2. 18.5 < BMI < 25 kg*m-2
- •3. Weight-stable for at least 90 days prior to participation (no change in
- •bodyweight, i.e. < 3kg).
- •4. Recreational active (performing non-competitive physical endurance exercise
- •at least two times per week with a minimum duration of 60 minutes per exercise
排除标准
- •1. Smoking
- •2. Performing regular resistance training (3+ times per week, carrying out
- •progressive training)
- •3. Subject following an overly imbalanced or restrictive diet as per
- •nutritional advice
- •4. Concurrent systemic disease and/or laboratory abnormalities considered by
- •investigators to be detrimental for the participants safety or potentially
- •interfering with the study procedures and/or study outcome
- •5. Hypertension (according to WHO criteria) and/or cardiovascular disease
- •6. Abdominal surgery interfering with gastrointestinal function, upon judgement
- •of the medical doctor, who will decide in-or exclusion based on the surgery
- •7. Participants who received antibiotics in the previous 90 days to the start
- •8. Use of other medication will be reviewed by a medical doctor, who will
- •decide on in- or exclusion based on the drug(s) used
- •9. Use of laxatives within 14 days prior to the study
- •10. Using medications for gastric or intestinal complaints
- •11. Drug use, interfering with any of the outcome parameters of this study; to
- •be decided by the person who is medically responsible for this study
- •12. Self-admitted lactose intolerance
- •13. Having donated blood in the 3 months prior to the study
- •14. Administration of probiotic or prebiotic supplements, investigational drugs
- •or participation in any scientific intervention study, which may interfere with
- •this study (to be decided by the principle investigator), in the 14 days prior
- •to the study
- •15. History of side effects towards intake of prebiotic supplements
- •16. Use of proton pump inhibitors
研究者
相似试验
招募中
不适用
Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipatioOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonconstipationACTRN12620001148965Metro South Hosptial and Health Service90
招募中
不适用
Exploring the modulatory effects of gut microbiota on cholangiocarcinoma progression in a patient-derived organoid modelC22.1Intrahepatic bile duct carcinomaCholangiocarcinomaDRKS00033188nimedizin Mainz, Klinik für Allgemein-, Viszeral- und Transplantationschirurgie20
已完成
不适用
The role of intestinal microbiota composition and intestinal permeability in the development of (complicated) diverticular disease.Outpocketings of colonic mucosa10013535NL-OMON35377Medisch Universitair Ziekenhuis Maastricht210
已完成
不适用
The influence of the intestinal microbiome on the development of postoperative complications after elective colon surgery - a prospective cohort studyK91.83T79.3Post-traumatic wound infection, not elsewhere classifiedDRKS00014059niversitätsklinikum FreiburgInstitut für Umweltmedizin und KrankenhaushygieneUni-Zentrum Naturheilkunde127
已完成
2 期
Modulation of small intestinal microbial composition and activity, systemic immune adaptation and blood transcriptional changes induced by 2-wks consumption with 2 fermented milk products; a randomized, exploratory, cross-over, double blind, controlled study in ileostomy patientscolectomyileostomy10017943NL-OMON45768niversiteit Maastricht16